Hcv inhibiting bi-cyclic pyrimidines

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/517 (2006.01) A61K 31/519 (2006.01) A61K 31/52 (2006.01) A61K 31/53 (2006.01) A61K 31/5377 (2006.01) A61P 1/16 (2006.01) A61P 31/14 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2577745

The present invention relates to the use of bi-cyclic pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to processes for preparation of such pharmaceutical compositions. The present invention also concerns combinat ions of the present bi-cyclic pyrimidines with other anti-HCV agents.

L'invention concerne l'utilisation de pyrimidines bicycliques comme inhibiteurs de réplication du VHC ainsi que leur utilisation dans des compositions pharmaceutiques susceptibles de traiter ou de combattre des infections par le VHC. L'invention concerne également des procédés permettant de préparer ces compositions pharmaceutiques. L'invention concerne enfin des combinaisons des pyrimidines bi-cycliques précitées avec d'autres agents anti-VHC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hcv inhibiting bi-cyclic pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hcv inhibiting bi-cyclic pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv inhibiting bi-cyclic pyrimidines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1888078

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.